Related references
Note: Only part of the references are listed.Efficacy and safety of amphotericin B deoxycholate versus N-methylglucamine antimoniate in pediatric visceral leishmaniasis: an open-label, randomized, and controlled pilot trial in Brazil
Myrlena Mescouto Borges et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2017)
HISTORICAL SERIES OF PATIENTS WITH VISCERAL LEISHMANIASIS TREATED WITH MEGLUMINE ANTIMONIATE IN A HOSPITAL FOR TROPICAL DISEASES, MACEIO-AL, BRAZIL
Lindon Johoson Diniz Silveira et al.
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO (2015)
Mortality and Case Fatality Due to Visceral Leishmaniasis in Brazil: A Nationwide Analysis of Epidemiology, Trends and Spatial Patterns
Francisco Rogerlandio Martins-Melo et al.
PLOS ONE (2014)
Safety and Efficacy of Single Dose versus Multiple Doses of AmBisome (R) for Treatment of Visceral Leishmaniasis in Eastern Africa: A Randomised Trial
Eltahir A. G. Khalil et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Risk Factors for Adverse Prognosis and Death in American Visceral Leishmaniasis: A Meta-analysis
Vinicius Silva Belo et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Liposomal amphotericin B as a treatment for human leishmaniasis
Manica Balasegaram et al.
EXPERT OPINION ON EMERGING DRUGS (2012)
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Jorge Alvar et al.
PLOS ONE (2012)
High frequency of asymptomatic Leishmania spp. infection among HIV-infected patients living in endemic areas for visceral leishmaniasis in Brazil
Marcela Orsini et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2012)
Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial
Ahmed Musa et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial
Shyam Sundar et al.
LANCET (2011)
Treatment of visceral leishmaniasis in children in the Central-West Region of Brazil
Y. M. Brustoloni et al.
INFECTION (2010)
Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India
Shyam Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Control of Visceral Leishmaniasis in Latin America-A Systematic Review
Gustavo A. S. Romero et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
New treatment approach in Indian visceral leishmaniasis: Single-dose liposomal amphotericin B followed by short-course oral miltefosine
Shyam Sundar et al.
CLINICAL INFECTIOUS DISEASES (2008)
Liposomal amphotericin B for the treatment of visceral leishmaniasis
Caryn Bern et al.
CLINICAL INFECTIOUS DISEASES (2006)
Amphotericin B treatment for Indian visceral leishmaniasis: Conventional versus lipid formulations
S Sundar et al.
CLINICAL INFECTIOUS DISEASES (2004)
Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: A multicenter study
S Sundar et al.
CLINICAL INFECTIOUS DISEASES (2003)
Two doses of a lipid formulation of amphotericin B for the treatment of Mediterranean visceral leishmaniasis
V Syriopoulou et al.
CLINICAL INFECTIOUS DISEASES (2003)
Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial
S Sundar et al.
BRITISH MEDICAL JOURNAL (2001)
Share Paper
